Event Details
Crinetics Pharmaceuticals will host a conference call and webcast on Monday, January 5, 2026 at 8:30 a.m. ET to provide an update on PALSONIFY™ (paltusotine) commercialization and disclose topline results from the fourth cohort of the Phase 2 trial of atumelnant in congenital adrenal hyperplasia.
Conference Call & Webcast
Monday, January 5, 2026 at 8:30 a.m. ET.
Domestic: 1-833-470-1428
International: 1-646-844-6383
Access Code: 640078
Live & Archived Webcast
To ensure a timely connection, it is recommended that participants connect at least 15 minutes prior to the scheduled start of the call.
